Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
- Jerusalem, G.
- Mariani, G.
- Ciruelos, E.M.
- Martin, M.
- Tjan-Heijnen, V.C.G.
- Neven, P.
- Gavila, J.G.
- Michelotti, A.
- Montemurro, F.
- Generali, D.
- Simoncini, E.
- Lang, I.
- Mardiak, J.
- Naume, B.
- Camozzi, M.
- Lorizzo, K.
- Bianchetti, S.
- Conte, P.
ISSN: 1569-8041, 0923-7534
Año de publicación: 2016
Volumen: 27
Número: 9
Páginas: 1719-1725
Tipo: Artículo